Hugh Rienhoff

Hugh Young Rienhoff was the founder of DNA Sciences, Inc. (founded in 1998), where the title held was Chairman & Chief Executive Officer from 1998 to 2001.
Dr. Rienhoff was the founder of FerroKin BioSciences, Inc. (founded in 2007), serving as Chief Executive Officer from 2007 to 2012.
Dr. Rienhoff was the founder of Imago BioSciences, Inc. (founded in 2012), holding the position of Chief Executive Officer & Director from 2012 to 2023.
Current jobs include Chairman at Odyssey Thera, Inc., Chairman at Parvus Therapeutics, Inc. since 2019, Director at Datahooks, Inc., Director at Attenua, Inc., Advisor at HealthCap AB, and Adjunct Scientist at Children's Hospital Oakland Research Institute.
Former jobs include Chairman at Wilson Therapeutics AB, Founding Director at Aurora Biosciences Corp., Director at Emdeon Corp., Director at Iconix Biosciences, Inc., Founding Director at WebMD, Inc., Director at Peptimmune, Inc., Director at Hydra Biosciences, Inc., Director at Abingworth Management, Inc., Director at Mydaughtersdna, Partner at NEA Management Co. LLC, and Faculty Member at The Johns Hopkins University.
Education includes a doctorate from The Johns Hopkins University and an undergraduate degree from Williams College.